Comparison

SARS-CoV-2 Spike RBD (receptor binding domain), 336-347 - Lys(Biotin-LC) - 0.1 mg

Item no. AS-65606
Manufacturer AnaSpec
Amount 0.1 mg
Category
Type Peptides
Specific against other
Purity Peak Area by HPLC ≥95%
Sequence H-Cys-Pro-Phe-Gly-Glu-Val-Phe-Asn-Ala-Thr-Arg-Phe-Lys(Biotin-LC)-NH2
Citations 1. Wan Y, Shang J, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020 Mar 17;94(7). 2. Chen Y, et al. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 2020 Feb 17.
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias CPFGEVFNATRF-K(Biotin-LC)-NH2
Shipping Condition Room temperature
Available
Manufacturer - Type
Catalog
Manufacturer - Applications
Receptor binding studies; Screening
Manufacturer - Category
Peptides
Manufacturer - Targets
Spike protein
Shipping Temperature
RT
Storage Conditions
- 20 °C
Molecular Weight
1854.3
Description
This peptide sequence represents residues 336-347 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.
Product Group
LB1A2Z
Research Area
Immunology and Infectious disease; Cell Signaling / 0
Sequence One-Letter Code
CPFGEVFNATRF-K(Biotin-LC)-NH2
GTIN
5400535177454
Usage
Research use

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close